Stay updated on Cabozantinib for PN in NF1: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically adding new locations in Washington D.C. and St. Louis, while removing previous references to Neurofibromatosis Type 1. Additionally, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    1%
    Check dated 2025-08-31T11:47:51.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T01:43:49.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-10T00:06:34.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.6%
    Check dated 2025-08-02T18:30:23.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.1%
    Check dated 2025-07-26T14:48:40.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.0%
    Check dated 2025-07-19T11:24:57.000Z thumbnail image

Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.